Last reviewed · How we verify
NVP-2203-R1
NVP-2203-R1 is a SGLT2 inhibitor Small molecule drug developed by NVP Healthcare. It is currently in Phase 3 development for Type 2 diabetes.
NVP-2203-R1 is a small molecule that targets the SGLT2 receptor.
NVP-2203-R1 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.
At a glance
| Generic name | NVP-2203-R1 |
|---|---|
| Sponsor | NVP Healthcare |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
By inhibiting SGLT2, NVP-2203-R1 reduces glucose reabsorption in the kidneys, thereby lowering blood glucose levels. This mechanism is particularly effective in treating type 2 diabetes.
Approved indications
- Type 2 diabetes
Common side effects
- Increased risk of genital yeast infections
- Increased risk of ketoacidosis
Key clinical trials
- To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients (PHASE3)
- To Evaluate the Safety and the Pharmacokinetics of NVP-2203 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NVP-2203-R1 CI brief — competitive landscape report
- NVP-2203-R1 updates RSS · CI watch RSS
- NVP Healthcare portfolio CI
Frequently asked questions about NVP-2203-R1
What is NVP-2203-R1?
How does NVP-2203-R1 work?
What is NVP-2203-R1 used for?
Who makes NVP-2203-R1?
What drug class is NVP-2203-R1 in?
What development phase is NVP-2203-R1 in?
What are the side effects of NVP-2203-R1?
What does NVP-2203-R1 target?
Related
- Drug class: All SGLT2 inhibitor drugs
- Target: All drugs targeting SGLT2
- Manufacturer: NVP Healthcare — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 2 diabetes
- Compare: NVP-2203-R1 vs similar drugs
- Pricing: NVP-2203-R1 cost, discount & access